Late-Breaking Clinical Trial outcomes from The VEINS Conference: CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment

Four late-breaking clinical trial outcomes from The VEINS Conference presented results from the CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment were present during the The VEINS Conference, taking place Oct. 28-30 in Las Vegas, NV.

Related Keywords

United States ,Georgia , ,Sakura ,Georgia General ,Poland ,Tbilisi ,Mahmood Razavi ,Jay Mathews ,Las Vegas ,Davidj Dexter ,Bradenton Cardiology Center ,Mercator Medsystems Inc ,Venous Endovascular ,Year Clinical Outcomes ,Deep Vein Thrombosis Patients Treated ,Mechanical Thrombectomy ,Sentara Vascular Specialists ,Clottriever Outcomes ,Inari Medical ,Venous Clinical Severity Score ,Numeric Pain Rating Scale ,Duo Venous Stent System ,Duo Hybrid ,Duo Extend ,Akura Medical Thrombectomy System ,Treating Venous Thromboembolism ,Akura Medical ,Augment Deep Vein Thrombosis Intervention ,Month Results ,Open Label Phase ,Sentara Vascular ,Mercator Medsystems ,